Copyright
©The Author(s) 2024.
World J Gastroenterol. Aug 7, 2024; 30(29): 3479-3487
Published online Aug 7, 2024. doi: 10.3748/wjg.v30.i29.3479
Published online Aug 7, 2024. doi: 10.3748/wjg.v30.i29.3479
Number of patients | n = 89 |
Age (median, yr) | 66 (26-93) |
Sex | |
Male | 69 (77.52) |
Female | 20 (22.47) |
Histology | |
Adenocarcinoma | 47 (52.80) |
Squamous cell carcinoma | 37 (41.57) |
Others | 4 (5.5) |
Tumor location | |
Gastroesophageal junction | 33 (70.21) |
Esophageal | 14 (29.78) |
Stage | |
Stage I-II | 25 (28.08) |
Stage III-IV | 54 (60.67) |
Presence of Helicobacter pylori | 4 (4.5) |
Adenocarcinoma | 3 (6.3) |
Squamous cell carcinoma | 1 (2.7) |
Previous PPI treatments | 86 (96.82) |
- Citation: López-Gómez M, Morales M, Fuerte R, Muñoz M, Delgado-López PD, Gómez-Cerezo JF, Casado E. Prevalence of Helicobacter pylori infection among patients with esophageal carcinoma. World J Gastroenterol 2024; 30(29): 3479-3487
- URL: https://www.wjgnet.com/1007-9327/full/v30/i29/3479.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i29.3479